Concepedia

K Cochran

KC

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

1990

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

K Cochran is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1990–2016

11

Publications

11

Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

Michael J. Robertson, K Cochran, Christine Cameron et al. · PubMed · 1996 · 348 citations

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Michael A. Caligiuri, Christine Murray, Michael J. Robertson et al. · Journal of Clinical Investigation · 1993 · 263 citations · Full text

, , +23

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

RJ Soiffer, Christine Murray, K Cochran et al. · Blood · 1992 · 198 citations · Full text

Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity.

Michael A. Caligiuri, Christine Murray, Robert J. Soiffer et al. · Journal of Clinical Oncology · 1991 · 102 citations

, , +17

Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells

Michael J. Robertson, Thomas Manley, Gabriella Pichert et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1995 · 95 citations

1–5 of 11